Investment Case
Burjeel Holdings is a leading private healthcare services provider in MENA with a compelling growth story. The Group boasts one of the largest healthcare networks in the UAE and has significant utilization headroom across its assets. Our leading practice, diagnostics, and research provide complex care for the whole community.
We are focusing on developing high-yield and highly complex care areas, leveraging and enabling the strength of our unique multi-brand portfolio. With our state-of-the-art infrastructure of high-growth assets and an expansive referral network, Burjeel Holdings remains uniquely positioned to deliver on its value-creation strategy of increasing patient yield and utilization while unlocking strategic expansion opportunities across the Gulf.
Established leader
in large, growing and resilient addressable market
Well-invested multi-brand network
covering the full socio-economic spectrum
World-class super-specialty care
proposition enabling patient yield growth
High-growth
asset mix
with significant utilization runway
Expanding geographically
through high-return and low-CAPEX opportunities
Accelerating digitization
to drive operational and medical excellence
Cash-generative business model
committed to delivering consistent shareholder return
Commitment to ESG
with low-risk rating & outstanding governance
1: Established leader in large, growing, and resilient addressable market
Burjeel Holdings is the UAE’s leading private healthcare provider and is well positioned to capture growth opportunities in Saudi Arabia and across the wider GCC, within an addressable healthcare market valued at $99 billion in 2023 and projected to reach $159 billion by 2029.
The Group benefits from strong healthcare demand driven by demographic trends, the rising prevalence of chronic diseases and growing medical tourism, supported by progressive regulatory frameworks encouraging private sector participation.
(2023)
2: Well-invested multibrand network covering the full socioeconomic spectrum
Burjeel Holdings’ well-invested and full-scale hub-and-spoke model enables the Group to capture value across the entire patient pathway through multiple touchpoints, driving revenue, brand engagement and Group loyalty.
Burjeel Holdings has established a unique suite of branded healthcare facilities catering to the whole community, including high-income Emiratis and local expats of varying incomes.
This allows the Group to maximise its potential to drive shareholder value.
incl. 20 hospitals
since inception
3: World-class super-specialty care proposition enabling patient yield growth
Burjeel Holdings has established an industry-leading capability to provide its patients with world-class complex medical care as an integral part of its strategy.
Focusing on key specialities, investing in subspecialties, and providing complex treatments drive patient yields and improve profitability.
By introducing Burjeel Medical City as a super-speciality unit, the Group is expected to increase its yields through its tertiary and quaternary offerings.
super-specialty care
price range
4: High-growth asset mix with significant utilization runway
Burjeel Holdings’ current infrastructure operates at approximately 67% capacity across inpatient and outpatient services.
Around 60% of the Group’s hospitals remain in the growth phase and currently operate below typical peak occupancy levels of 80%—85%, indicating significant capacity for volume expansion as these assets mature.
The Group aims to increase network utilization to at least 80% across both inpatient and outpatient services in the medium term.
in growth stage
5: Expanding geographically through high-return and low-CAPEX opportunities
Burjeel Holdings’ expansion strategy covers several approached to unlock solid growth potential and improve its value proposition.
The Group is deepening its UAE presence through community-based expansion, accelerating regional growth with disruptive, high-demand offerings in Saudi Arabia, and scaling a de-risked, CAPEX-light O&M platform across the Gulf and Africa.
added in mid-term
from expansion
6: Accelerating digitization to drive operational and medical excellence
Burjeel Holdings continues integrating new digital technologies across its network to benefit all its stakeholders, transform the patient experience and improve operational efficiency.
The Group’s focus on digital transformation promotes investor attractiveness by improving patient outcomes and facilitating more excellent patient acquisition through its omnichannel communication platform.
integration by 2027
automation via AI (2025)
7: Cash-generative business model committed to delivering consistent shareholder return
Based on four interconnected pillars, Burjeel Holdings’ proven cash-generative business model has delivered impressive financial results underpinned by operational excellence.
This approach’s success results in robust margin expansion drivers, compelling asset economics, and strict capital discipline.
8: Commitment to ESG with low-risk rating & outstanding governance
The Group’s new long-term ESG strategy aims to position Burjeel Holdings as an ethical leader in the healthcare industry with solid commitments to service and operational excellence, ensuring the best patient care while promoting a sustainable and healthy work environment for its employees.
The Group also upholds strong governance, transparency, and accountability to foster patient trust, reflected in its Sustainalytics ‘Low-Risk’ ESG Rating.
Sustainalytics rating
directors